Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian McKeith

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Alzheimer'S Research & Therapy|August 4, 2016
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer's diseaseFrederic Blanc, Sean J Colloby, Benjamin Cretin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 14, 2007
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsyZuzana Walker, Evelyn Jaros, Rodney W H Walker, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2003
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disordersIrene Litvan, Kailash P Bhatia, David J Burn, et al.
Psychological Medicine|April 26, 2018
Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodiesAlan J Thomas, Paul Donaghy, Gemma Roberts, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2016
Effect Size Analyses of Souvenaid in Patients with Alzheimer's DiseaseJeffrey Cummings, Philip Scheltens, Ian McKeith, et al.
Molecular Neurodegeneration|January 23, 2019
Dementia with Lewy bodies: an update and outlookTiago Fleming Outeiro, David J Koss, Daniel Erskine, et al.
The Lancet. Neurology|March 17, 2007
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre studyIan McKeith, John O'Brien, Zuzana Walker, et al.
Journal of Psychopharmacology (Oxford, England)|January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for PsychopharmacologyJohn T O'Brien, Clive Holmes, Matthew Jones, et al.
Translational Neurodegeneration|May 1, 2022
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendationsFederico Rodriguez-Porcel, Kathryn A Wyman-Chick, Carla Abdelnour Ruiz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 14, 2014
Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imagingJohn P Seibyl, Andreas Kupsch, Jan Booij, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Alzheimer'S Research & Therapy|August 4, 2016
Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer's diseaseFrederic Blanc, Sean J Colloby, Benjamin Cretin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 14, 2007
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsyZuzana Walker, Evelyn Jaros, Rodney W H Walker, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2003
Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disordersIrene Litvan, Kailash P Bhatia, David J Burn, et al.
Psychological Medicine|April 26, 2018
Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodiesAlan J Thomas, Paul Donaghy, Gemma Roberts, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2016
Effect Size Analyses of Souvenaid in Patients with Alzheimer's DiseaseJeffrey Cummings, Philip Scheltens, Ian McKeith, et al.
Molecular Neurodegeneration|January 23, 2019
Dementia with Lewy bodies: an update and outlookTiago Fleming Outeiro, David J Koss, Daniel Erskine, et al.
The Lancet. Neurology|March 17, 2007
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre studyIan McKeith, John O'Brien, Zuzana Walker, et al.
Journal of Psychopharmacology (Oxford, England)|January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for PsychopharmacologyJohn T O'Brien, Clive Holmes, Matthew Jones, et al.
Translational Neurodegeneration|May 1, 2022
Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendationsFederico Rodriguez-Porcel, Kathryn A Wyman-Chick, Carla Abdelnour Ruiz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 14, 2014
Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imagingJohn P Seibyl, Andreas Kupsch, Jan Booij, et al.
Pageof 8